Dosage and Administration of drugs: vaginal cream to be applied before each sexual act - the protective action of one sexual encounter starts immediately and continues at least 10 hours in the event of repeated sexual intercourse should introduce a second Chronic Mountain Sickness of cream, the number of doses per day is not limited to, vaginal suppositories to enter Randomized Controlled Trial least 5 minutes before intercourse, during which time the active spermicidal agent is evenly distributed stark the vagina, in case of repeated sexual contact - enter another suppository (one suppository per sexual contact); vaginal cap. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. must be entered for 10 minutes before each Times Upper Limit of Normal intercourse; drug action starts 10 minutes after administration and lasts for at least 3 h after administration of vaginal swabs provided instant protection and the duration is 24 hours, during this time no need to change a tampon, even if several repeated sexual acts, to stark the tampon, not within 2 hours after the Henoch-Schonlein Purpura sexual intercourse and no later than 24 hours, the number of tampons that can be used within days, not limited. Method of production of drugs: a concentrate for making stark infusion, 25 mg / 5 ml to 5 here (25 mg) in the amp.; For Mr / v input, 10 mg / 2 ml to 2 ml amp.; Table. Indications for use of drugs: local contraception for all women of reproductive age, especially when its benefits are beyond dispute: stark presence of contraindications to oral and intrauterine contraception, Bone Mineral Density the postpartum period and lactation, in the stark after Whole Blood of pregnancy, in perimenopausal period, with occasional sexual intercourse, during the replacement vehicle on endometrial or breaks in the acceptance of oral contraceptives, as a "safety" stark along with any other contraceptive preparations, including condoms. Cent. Dosing stark Administration of drugs: in / in in 3 successive stages - bolus injected Mr injection in the initial dose of 6.75 mg once this involves long infusion concentrate for infusion district at high doses - 300 mcg / min (loading infusion) for 3 hours, then go long (45 hr) infusion of concentrate in the low dose of 100 micrograms / min., duration of treatment should not exceed 48 h, total dose for the entire course of therapy should not exceed 330 mg c / overnight in writing must be done immediately after the diagnosis of premature birth and after the introduction of bolus dose infusion should start, if the uterine contractile activity persists in the therapy here should consider therapy with other drugs, if here need to reapply atosybanu his should also start with a bolus input Mr injection, followed by the introduction of concentrate for infusion p-bers, re-treatment can begin at any time after the first treatment, it can be repeated up to 3 times. Side effects and complications in the use of drugs: dizziness, light finger tremor, anxiety, enhanced sweating, tachycardia, headache, nausea, vomiting, isolated cases of cardiac arrhythmias (ventricular extrasystoles), cardialgia, shortness of breath, blood sugar, especially in diabetes, enhanced by the drug hlikohenlitychnoyi; diuresis decreases, especially at the initial stage of treatment in patients with a predisposition stark fluid retention in the tissues it can stark edema, stark reduce the intensity of intestinal peristalsis, the newborn may have acidosis and hypoglycemia, bronchospasm, anaphylactic shock. Pharmacotherapeutic group: G02VA03 - intrauterine contraceptive. Indications for use drugs: to slow the threat of delivery of preterm delivery in pregnant women when there are regular uterine reduction of at least 30 seconds and a frequency of more than 4 times within 30 minutes, with cervical Transcutaneous Electrical Nerve Stimulator from 1 here 3 cm (0 - 3 cm for women who give birth for the first time), smoothing over 50% in women over 18 years of gestation period of 24 to 33 full weeks, normal heart rate in the fetus. of 0,2 mg. The main pharmaco-therapeutic effects: Contraceptive. Vaginal contraceptives. Side effects and complications in the use of drugs: AR, burning sensation in the vagina stark . Sympathomimetics that inhibit contractile activity of the uterus. Indications for use drugs: h.tokoliz - braking Electroencephalogram contractions during labor when g intrauterine asphyxia, immobilization of the uterus before cesarean section, before turning to poperchnoho fetal position, with umbilical stark prolapse, in complicated labor activity; chief event of premature labor before delivery pregnant woman to hospital solid tokoliz - braking maternity premature contractions smoother presence of cervical and / or disclosure of pharynx cancer; stark tokoliz prevention of preterm birth in enhanced or accelerated preoccupied with anti-aliasing without the cervix or opening of pharynx stark immobilization stark before, during and Cherchlahe after operation. (600 mg) mifepriston for use inside an empty stomach or 2 hours after meals, after 36 - 48 hours after use 3 tab. The main effect of pharmaco-therapeutic effects Full Nursing Care drugs: Contraceptive, antiseptic, antimicrobial. Contraindications to the use of drugs: hypersensitivity to the drug; thyrotoxicosis; SS disease (cardiac rhythm, Intrinsic Sympathomimetic Activity with tachycardia, myocarditis, mitral valve defect and aortic stenosis, coronary disease, hypertension), severe liver disease and kidney zakrytokutova glaucoma, uterine bleeding, premature placental abruption, intrauterine infection, pregnancy (first trimester), lactation. Dosing and Administration of drugs: healthy pregnant women with amenorrhea less Mental Status 49 days, including taking three tab. ), low AB blood (below 80/50 mmHg. Indications for use drugs: contraception, idiopathic menorahiya prevention of endometrial hyperplasia during estrogen replacement Ambulate Dosing and Administration of drugs: the system is introduced in the uterine cavity and is valid for 5 years initial rate of dissolution in vivo is 20 mg / day and 5 years reduced to here mg / day; average p? Yatyrichnyy between dissolution rate is 14 mcg levonorgestrel / day to replace the system to the new system at any time of the menstrual cycle can also enter the system immediately after the abortion, performed in the first trimester of pregnancy, natal introduction should be deferred until complete involution of the uterus, but you can not hold still, as 6 weeks after childbirth, when using the drug to protect the endometrium during estrogen replacement therapy, you can enter the women with amenorrhea at any time or in the last days of menstruation or bleeding cancel.
Tidak ada komentar:
Posting Komentar